ICYMI: ���These results support the use of tirzepatide for the treatment of type 2 #diabetes and provide further evidence for the potential role of this dual GIP and GLP-1 receptor agonist as the next step in the treatment continuum." @LillyPad @NRITrials https://t.co/s0uqNv9Mhd
Join us this weekend at #Lynwood City Park. We will be providing #glucose testing for the #community!
Únase a nosotros este fin de semana en Lynwood City Park. ¡Proporcionaremos pruebas de glucosa para la comunidad!
Know your #liver's #health and receive $40! Limited time offer. Call us now for more information.
¡Conozca la #salud de su #hígadoy reciba $40! Oferta de tiempo limitado. Llamenos ahora para mas informacion.
Nonalcoholic steatohepatitis #NASH is a chronic condition that damages your #liver. There is no treatment, and unmanaged, it can lead to serious health problems. The ENliven Study is researching a possible #treatment for NASH.
To learn more, contact us at 1-877-794-2267
In this interview, Juan Frias, MD, of @NRITrials, breaks down results of a post-hoc analysis of the AWARD-11 study examining expanded doses of dulaglutide (Trulicity) according to baseline HbA1c levels.
#Diabetes
https://t.co/MUh8y8Knu3
https://t.co/MUh8y8Knu3
A BIG thank you to all clinical trial professionals for what you do every day to improve the health of others. We'd also like to thank all of our dedicated patients who are making the world a healthier place through their clinical trial participation. #clinicaltrialsday#CTD2021
To all nurses and especially our lovely nurses at NRI, we would like to take this opportunity to express our gratitude and wish you a Happy Nurses Day!!! Thank you for all that you do!
#thankyou#gratitude#nurses#healthcare#HealthcareHeroes
Esta sobrepeso? ¡Es posible que podamos proporcionar algunas respuestas!
Struggling with your weight? We may be able to provide some answers!
#sobrepeso#obesity#overweight
Results from a study led by Dr. Frias and the NRI team showed BIO89-100 reduces liver fat and lowers triglycerides in adults with NASH.
#health#medicine#clinicalresearch
https://t.co/hFwbUbWFij
Nonalcoholic steatohepatitis or #NASH is liver inflammation caused by a buildup of fat in the liver. Some risk factors include #obesity, #highcholesterol, and #type2diabetes. Do you think you may have NASH? Contact NRI for more information.
We can't go without recognizing our very own Doctors at NRI. We truly appreciate & admire your dedication to patient care and research. Thank you for all that you have done. May your days be wonderful and healthy like you make it for others. #nationaldoctorsday#healthcareheroes
Check out this interview with Juan Frias, MD, where he dives deeper into the results of phase 2 data from a study examining once-weekly basal insulin Fc in patients with type 2 #diabetes.
#ENDO2021@NRITrials
https://t.co/pzzbRDFjXh